Spur Therapeutics’ Post

Did you miss out on our last webinar? Watch the full episode here: https://lnkd.in/eU7Vj8FD Be part of the conversation & join us for the final webinar in our series on February 27th 1-3pm ET! We will be exploring the future of therapeutics in genomic medicine. Register at https://lnkd.in/gppCGBgB #therapeutics #rarediseases #geneticcounseling #genechat

Most-Read Precision Medicine Stories in 2023: Immunotherapy, Lay Offs, Regulation, Adoption, Access. This year, stories about new targetable biomarkers and genetic testing tools, the impact of economic headwinds and regulation, and access disparities were most popular with readers. http://ow.ly/VqMf1057frq

Words cannot express how proud some of us are today, having been a part of this journey from the earliest of days. Special mention to the original scientific think-tank and my partners Bill Lundberg, Chad Cowan, Andrew Kernytsky, TJ Cradick, Ph.D. and Michelle Lin. It is even more remarkable to know that a journey we started almost a decade ago, is paving the way for so much more today, including the expansion into allogeneic transplants for curing hematological malignancies at companies like Vor Bio, that some of us privileged to be a part of. Long-live Genetic Medicines. Long-live good, rigorous Science! This is just the beginning. Read more from STAT

Genetic Biomarker Prediction Using Whole Slide Images and Prompts: A New Frontier in CRC Diagnosis *** PromptBio enhances genetic biomarker prediction by selecting relevant image patches from whole slide images, grouping them into specific pathological components, and modeling their interactions. This method, validated on significant datasets, achieved superior accuracy compared to other methods, showing promise for clinical applications. *** https://lnkd.in/e8gF6xjz

#OrigiGator Atsena Therapeutics dosed its first patient in its Phase I/II clinical trial of ATSN-201 to evaluate the treatment's efficacy in treating X-lined retinoschisis (XLRS). Based on innovations discovered in the University of Florida College of Medicine by Dr. Shannon Boye, ATSN-201 leverages one of the company’s novel spreading capsids, AAV.SPR, to overcome the challenges associated with other methods of treating XLRS. This new form of genetic medicine is sure to revolutionize the field. 🧬 Find more info, here. ▶️ https://bit.ly/atsena1st

Top 10 Precision Medicine Stories in 2023: Immunotherapy, Lay Offs, Regulation, Adoption and Access. This year, stories about new targetable biomarkers and genetic testing tools, the impact of economic headwinds and regulation, and access disparities were most popular with readers. http://ow.ly/hqGx1057fmA

The new Fragment Sequencing approach developed by researchers at ETH Zurich is opening up new insights into single-cell transcriptomics, and expanding the scope of what we know about cell-to-cell interaction, disease progression and tumorigenesis. Read our summary of the study to learn more : 👉 https://lnkd.in/dRQDGZ6N #BDBiosciences #SingleCellAnalysis #SingleCell #SpatialBiology #Rhapsody #BD 

The new Fragment Sequencing approach developed by researchers at ETH Zurich is opening up new insights into single-cell transcriptomics, and expanding the scope of what we know about cell-to-cell interaction, disease progression and tumorigenesis. Read our summary of the study to learn more : 👉 https://lnkd.in/dRQDGZ6N #BDBiosciences #SingleCellAnalysis #SingleCell #SpatialBiology #Rhapsody #BD 

BD Rhapsody goes spatial 👀. Read a summary of the study at: https://lnkd.in/dRQDGZ6N #BDBiosciences #SingleCellAnalysis #SingleCell #SpatialBiology #Rhapsody #BD